| Ytd | -43.39% | |
| 1y | -46.06% |
| Open | 68.18 | Prev Close | 67.85 | Low | 68.02 | High | 69.66 | Mkt Cap | 2.38B |
| Vol | 111.00K | Avg Vol | 1.36M | EPS | 4.37 | P/E | 15.78 | Forward P/E | 21.20 |
| Beta | 1.88 | Short Ratio | 6.27 | Inst. Own | 108.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 77.74 | 200-d Avg | 113.58 | 1yr Est | 117.33 |
TD Cowen analyst Joshua Jennings reiterates TransMedics Group (NASDAQ:TMDX) with a Buy and mainta
TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion inve
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the p
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and lowers the p
Canaccord Genuity analyst William Plovanic maintains TransMedics Group (NASDAQ:TMDX) with a Buy a
TD Cowen analyst Joshua Jennings maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers
Stifel analyst Thomas Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and lowers th
Piper Sandler analyst Matt O'Brien maintains TransMedics Group (NASDAQ:TMDX) with a Overweigh
Needham analyst Mike Matson maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the p
U.S. stock futures up, Dow gains 200 points. Upstart (UPST) falls 11.8% on weak Q1 EPS and FY26 sale
Veeco Instruments Inc (NASDAQ: VECO) rose in pre-market trading after reporting Q1 results and affir
TransMedics Group (NASDAQ:TMDX) affirms FY2026 sales outlook from $727.000 million-$757.000 million
TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.30 per share which missed the analyst
The proposed strategic investment is subject to the satisfaction of closing conditions specified in
Unveils New Controlled Hypothermic Organ Preservation System (CHOPS) to Expand its Product Portfolio
Choice Hotels, Avis Budget and Lucid stock all have short-interest above 50% of their free floats.
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outp
Stifel analyst Thomas Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises th
JP Morgan analyst Allen Gong maintains TransMedics Group (NASDAQ:TMDX) with a Neutral and raises
Oppenheimer analyst Suraj Kalia maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and r
Piper Sandler analyst Matt O'Brien maintains TransMedics Group (NASDAQ:TMDX) with a Overweigh
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outp
Needham analyst Mike Matson maintains TransMedics Group (NASDAQ:TMDX) with a Buy and raises the p
TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.57 per share which beat the analyst c
TransMedics Group (NASDAQ:TMDX) sees FY2026 sales of $727.000 million-$757.000 million vs $723.991 m
TransMedics Gr (NASDAQ:TMDX) reported quarterly sales of $160.764 million which beat the analyst con
Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby,
Here's a look at the top ten. most shorted stocks in the market, including Lucid, Hims & Her
Here's a list of the most heavily shorted stocks with market caps above $2 billion and free floa
Canaccord Genuity analyst William Plovanic maintains TransMedics Group (NASDAQ:TMDX) with a Buy a
Here's a look at the top 10 most shorted stocks in the market right now, including Lucid, MARA,